As of 2026-04-03, the Relative Valuation of Cue Biopharma Inc (CUE) is (5.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.18 USD, the upside of Cue Biopharma Inc based on Relative Valuation is -3097.8%.
The range of the Relative Valuation is (5.13) - (5.41) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.4x - 24.3x | 22.4x |
| Forward P/E multiples | 20.8x - 21.9x | 21.4x |
| Fair Price | (5.13) - (5.41) | (5.39) |
| Upside | -2953.8% - -3104.7% | -3097.8% |
| Date | P/E |
| 2026-04-02 | -0.73 |
| 2026-04-01 | -0.82 |
| 2026-03-31 | -0.93 |
| 2026-03-30 | -0.92 |
| 2026-03-27 | -0.97 |
| 2026-03-26 | -1.02 |
| 2026-03-25 | -1.07 |
| 2026-03-24 | -1.03 |
| 2026-03-23 | -1.08 |
| 2026-03-20 | -1.08 |
| 2026-03-19 | -1.07 |
| 2026-03-18 | -1.07 |
| 2026-03-17 | -1.10 |
| 2026-03-16 | -1.26 |
| 2026-03-13 | -1.15 |
| 2026-03-12 | -1.23 |
| 2026-03-11 | -1.32 |
| 2026-03-10 | -1.26 |
| 2026-03-09 | -1.22 |
| 2026-03-06 | -1.21 |
| 2026-03-05 | -1.17 |
| 2026-03-04 | -1.22 |
| 2026-03-03 | -1.20 |
| 2026-03-02 | -1.14 |
| 2026-02-27 | -1.13 |
| 2026-02-26 | -1.17 |
| 2026-02-25 | -1.15 |
| 2026-02-24 | -1.14 |
| 2026-02-23 | -1.14 |
| 2026-02-20 | -1.15 |
| 2026-02-19 | -1.19 |
| 2026-02-18 | -1.20 |
| 2026-02-17 | -1.18 |
| 2026-02-13 | -1.24 |
| 2026-02-12 | -1.22 |
| 2026-02-11 | -1.30 |
| 2026-02-10 | -1.37 |
| 2026-02-09 | -1.31 |
| 2026-02-06 | -1.30 |
| 2026-02-05 | -1.28 |
| 2026-02-04 | -1.25 |
| 2026-02-03 | -1.34 |
| 2026-02-02 | -1.38 |
| 2026-01-30 | -1.36 |
| 2026-01-29 | -1.46 |
| 2026-01-28 | -1.50 |
| 2026-01-27 | -1.58 |
| 2026-01-26 | -1.48 |
| 2026-01-23 | -1.54 |
| 2026-01-22 | -1.48 |